Good news. If the company is able to successfully produce reliable blood tests for a range of conditions currently requiring invasive and expensive procedures it will result in better health outcomes for more people, especially those who may not have the means to access current procedures, especially in a timely manner.
Ann: Promarker pipeline - Oesophageal cancer diagnostic update, page-2
Add PIQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
89.0¢ |
Change
-0.010(1.11%) |
Mkt cap ! $117.9M | |||
| Open | High | Low | Value | Volume |
| 90.0¢ | 90.0¢ | 89.0¢ | $47.94K | 53.67K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 10000 | 88.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 89.0¢ | 7294 | 1 |
View Market Depth
| Last trade - 10.21am 01/08/2024 (20 minute delay) ? |
| PIQ (ASX) Chart |